New combo therapy aims to smooth blood sugar swings in diabetes
NCT ID NCT07442006
First seen Mar 18, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study tests whether adding another drug to metformin and an SGLT-2 inhibitor can improve blood sugar stability in people with type 2 diabetes. About 178 adults with poor blood sugar control will receive the combination therapy for 12 weeks. The main goal is to see if it reduces daily glucose fluctuations and increases time in the healthy blood sugar range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Catholic University of Korea, Bucheon St. Mary's Hospital, Principal Investigator
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.